Evidence map›Paper›PMID 39377893›Full record

ArticleMolecular diversity2025

Larvicidal activity, molecular docking, and molecular dynamics studies of 7-(trifluoromethyl)indolizine derivatives against Anopheles arabiensis.

Harshada Rambaboo Singh, Priya Tiwari, Pran Kishore Deb, Gourav Rakshit, Prasenjit Maity, Viresh Mohanlall, Raquel M Gleiser, Katharigatta N Venugopala, Sandeep Chandrashekharappa

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Harshada Rambaboo SinghDepartment of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Raebareli, Near CRPF Base Camp, Transit Campus, Bijnor-Sisendi Road, Sarojini Nagar, Lucknow, UP, 226002, India.
Priya TiwariDepartment of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Raebareli, Near CRPF Base Camp, Transit Campus, Bijnor-Sisendi Road, Sarojini Nagar, Lucknow, UP, 226002, India.
Pran Kishore DebDepartment of Pharmaceutical Sciences and Technology, Birla Institute of Technology (BIT), Mesra, Ranchi, Jharkhand, 835215, India. prankishoredeb@bitmesra.ac.in.
Gourav RakshitDepartment of Pharmaceutical Sciences and Technology, Birla Institute of Technology (BIT), Mesra, Ranchi, Jharkhand, 835215, India.
Prasenjit MaityDepartment of Pharmaceutical Sciences and Technology, Birla Institute of Technology (BIT), Mesra, Ranchi, Jharkhand, 835215, India.
Viresh MohanlallDepartment of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, Durban, 4000, South Africa.
Raquel M GleiserCREAN-IMBIV (UNC-CONICET), Universidad Nacional de Cordoba, Av. Valparaiso s.n., and FCEFyN, Av. V. Sarsfield 299, 5000, Cordoba, Argentina.
Katharigatta N VenugopalaDepartment of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, Durban, 4000, South Africa.
Sandeep ChandrashekharappaDepartment of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Raebareli, Near CRPF Base Camp, Transit Campus, Bijnor-Sisendi Road, Sarojini Nagar, Lucknow, UP, 226002, India. c.sandeep@niperraebareli.edu.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel series of 7-(trifluoromethyl)indolizine derivatives (4a-4n) was synthesized using a 1,3-Dipolar cycloaddition reaction. Structure elucidation of the synthesized compounds was done using various spectroscopic techniques. Compounds were assessed for their larvicidal activity against Anopheles arabiensis. Exposure of Anopheles arabiensis larvae to a series of 7-(trifluoromethyl)indolizine at 4 µg/mL for 24 and 48 h resulted in moderate to high larval mortality rates. Among them, compounds 4b, 4a, 4g, and 4m exhibited the most promising larvicidal activities, with mortality rates of 94.4%, 93.3%, 80.00%, and 85.6%, respectively, compared to controls, Acetone and Temephos. The structural activity relationship analysis of the evaluated compounds revealed that substitution with halogens or electron-withdrawing groups (CN, F, Cl, Br) at the para position of the benzoyl group is crucial for achieving promising larvicidal activity. Molecular docking studies were carried out involving six potential larvicidal target proteins to predict how the tested compounds might work. Compounds 4a and 4b showed strong binding to the Mosquito Juvenile Hormone-Binding Protein (5V13). Molecular dynamics (MD) simulations confirmed the stability of the protein-ligand complexes over the simulation period, reinforcing the reliability of the docking results. Compounds 4a and 4b also exhibited favourable ADMET profiles, showing high oral bioavailability, good permeability, moderate distribution, low plasma protein binding, sufficient metabolic stability, efficient renal clearance and low toxicity. Given the crucial role of Juvenile Hormone in regulating gene expression and developmental pathways through receptor interactions, compounds 4a and 4b show promise as inhibitors of this protein. Inhibiting this process could hinder larval growth and reproduction, presenting a promising approach for early-stage mosquito larvicidal activity. Therefore, compounds 4a and 4b represent lead candidates for further optimization and the development of new larvicidal agents.

Indexed as

AnophelesIndolizinesInsecticidesMolecular Docking SimulationMolecular Dynamics SimulationAnimalsLarvaStructure-Activity RelationshipIndolizinesInsecticidesAnopheles arabiensisCharacterizationIndolizineLarvicidal activityMalariaMosquito Juvenile Hormone-Binding ProteinSynthesis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.